88 DAFTAR PUSTAKA Abe M, Okada K, Soma M (2011). Anti

DAFTAR PUSTAKA
Abe M, Okada K, Soma M (2011). Anti diabetic agents in patients with chronic
kidney disease and end-stage renal disease on dialysis : metabolism and
clinical practice. Current Drug Metabolism, 12 : 57-69.
Al-Ramahi R (2012). Medication prescribing patterns among chronic kidney
disease patients in a hospital in Malaysia. Saudi J Kidney Dis Transpl, 23
(2): 403-408.
Al-Wakeel JS, Miewalli AH, Al-Mohaya S, Abu-Aisha H, Tarif N, Malik GH, et
al. (2002). Morbidity and mortality in ESRD patients on dialysis. Saudi J
Kidney Dis Transplant, 13 (4) : 473-477.
Altieri P, Sau G, Cao R, Barracca A, Menneas A, Micchittu B, et al. (2002).
Immunosuppresive treatment in dialysis patient. Nephrol Dial Transplant,
17 (8) : 2-9.
Amin LZ (2014). Pemilihan antibiotik yang rasional. Medicinus, 27 (3) : 40-45.
Amini M, Khosravi M, Baradaran HR, Atlasi R (2015). Vitamin B12
supplementation in end stage renal disease : a systemmic review. Med J
Islam Repub Iran, 29 : 167.
Appel GB, Radhakrishnan J, Ginzler EM (2005). Use of mycophenolate mofetil in
autoimmune and renal diseases. Transplantation, 80 (2) : 265-271.
Arici M (2012). Ideal criteria for starting chronic hemodialysis : numbers,
symptoms, or an alerting traffic light system. Nephron Clin Pract, 120 :
17-24.
Arnouts P, Bolignano D, Nistor I, Bilo H, Gnudi L, Heaf J, et al. (2014). Glucoselowering drugs in patients with chronic kidney disease : A narrative
review on pharmocokinetic properties. Nephrol Dial Transplant, 29 (7) :
1284-1300.
Ashley C dan Currie A (2009). The renal drug handbook 3th edition. New York :
Radcliffe Publishing.
Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystyn H (2000).
Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J
Kidney Dis, 35 (5) : 827-831.
Ayuandira E (2014). Pengaruh dukungan sosial terhadap penerimaan diri pasien
gagal ginjal kronik dengan terapi hemodialisa di RSUP DR. M. Djamil
Padang. Fakultas Kedokteran. Skripsi, Universitas Andalas, Padang.
Fakultas Kedokteran Universitas Andalas
88
Badan POM RI (2015). Pusat informasi obat nasional badan pengawas obat dan
makanan. http://pionas.pom.go.id. Diakses Juni 2017.
Bargman JM dan Skorecki K (2013). Penyakit ginjal kronik. Dalam : Jameson JL
dan Loscalzo J (eds). Harrison nefrologi dan gangguan asam-basa. Jakarta:
EGC.
Berman SJ, Johnson EW, Nakatsu C, Alkan M, Chen R, LeDuc J (2004). Burder
of infection in patients with end-stage renal disease requiring long-term
dialysis. Clin Infect Dis, 39 (12) : 1747-1753.
Berman S (2010). Infections in patients undergoing chronic dialysis.
http://www.antimicrobe.org/e41.asp. Diakses Januari 2017.
Berns JS dan Glickman JD (2016). Management of hyperglycemia in patient with
type 2 diabetes and pre-dialysis chronic kidney disease or end-stage renal
disease.
https://www.uptodate.com/contents/management-ofhyperglycemia-in-patients-with-type-2-diabetes-and-pre-dialysis-chronickidney-disease-or-end-stage-renal-disease. Diakses Januari 2017.
Betonico CCR, Titan SMO, Giannella ML, Nervy M, Queiroz M (2016).
Management of diabetes mellitus in individuals with chronic kidney
disease : therapeutic perspectives and glycemic control. Clinics, 71 (1) :
47-53.
Boubaker K, Kaaroud H, Maiz HB, Kheder A (2012). Characteristics of Graves’
disease in haemodialysis patients. Journal of Endocrinology and
metabolism, 2 (6) : 212-215.
Cardone KE, Bacchus S, Assimon MM, Pai AB, Manley HJ (2010). Medicationrelated problems in CKD. Adv Chronic Kidney Dis Journal, 17 (5) : 404412.
Cavanaugh KL (2007). Diabetes management issues for patients with chronic
kidney disease. Clinical Diabetes, 25 (3) : 90-97.
Chonchol M dan Spiegel DM (2009). The Patient with Chronic Kidney Disease,
Dalam : Schrier RW (ed). Manual of Nephrology 7th edition. Philadelphia
: Lippincott Williams & Wilkins.
Collins AJ, Foley RN, Gilbertson DT, Chen SC (2009). The state of chronic
kidney disease, ESRD, and morbidity and mortality in the first year of
dialysis. Clin J Am Soc Nephrol, 4 : S5-S11.
Cousin L, Berre ML, Vacher VL, Izzedine H, Deray G (2003). Dosing guidelines
for fluconazole in patients with renal failure. Nephrol Dial Transplant, 18
(11) : 2227-2231.
Coyne DW (2011). Management of chronic kidney disease comorbidities.
http://www.medscape.org/viewarticle/736181. Diakses Maret 2017.
Fakultas Kedokteran Universitas Andalas
89
Damian F dan Marteen T (2012). A stepped care approach to the management of
chronic kidney disease. Dalam : Taal M, Chertow G, Marsden P, Skorecki
K, Yu A, Brenner B (eds). Brenner and Rector’s The Kidney, 9th edition.
Philadelphia : Elsevier Saunders.
Dasari P, Venkateshwarlu K, Venisetty K (2014). Management of comorbidities
in chronic kidney disease : A prospective observational study. Int J Pharm
Pharm Sci, 6 (2) : 363-367.
Depta JP dan Bhatt DL (2008). Aspirin and platelet adenosine diphospate receptor
antagonist in acute coronary syndromes and percutaneous coronary
intervention : role in therapy and strategies to overcome resistance. Am J
Cardiovasc Drugs, 8 (2) : 91-112.
Dezsi CA (2016). The different therapeutic choices with ARBs – Which one to
give? When? Why? Am J Cardiovasc Drugs, 16 (4) : 255-266.
Dharmeizar (2012). Epidemiologi dan penatalaksanaan penyakit ginjal kronik.
Dalam : Sja’bani M, Dharmeizar, Lestariningsih, Purwanto B (eds).
Naskah lengkap simposium nasional peningkatan pelayanan penyakit
ginjal kronik masa kini dan Indonesia Renal Registry Joglosemar 2012.
Yogyakarta : Pernefri Wilayah Yogyakarta.
Dheepan NB, Sarala N, Raghavendra PB (2015). Drug utilization study in
hemodialysis unit in a tertiary care centre in Kolar. IJPBS, 5 (1) : 72-78.
Doogue MP dan Polasek TM (2011). Drug dosing in renal disease. Clin Biochem
Rev, 32 (2) : 69-73.
Duerden M, Avery T, Payne R (2013). Polypharmacy and medicines optimisation
making it safe and sound. London : The King’s Found.
Fox CH, Voleti V, Khan LS, Murray B, Vassalotti J (2008). A quick guide to
evidence-based chronic kidney disease care for the primary care physician.
Postgraduate Medicine, 120 (2) : 1-6.
Gallieni M, Mezzina N, Pinerolo C, Granata A (2012). Sex and gender differences
in Nephrology. Dalam : Sabine OP, Vera RZ (eds). Sex and gender aspects
in clinical medicine. London : Springer-Verlag.
George S, Acharya LD, Prabhu R, Mallayasamy S (2013). Management and
treatment outcome of complication of chronic kidney disease patients in a
South Indian tertiary care hospital. International Journal of Pharmacology
and Clinical Sciences, 2 (4) : 113-120.
Goldberg I dan Krause I (2016). The role of gender in chronic kidney disease.
European Medical Journal, 1 (2) : 58-64.
Fakultas Kedokteran Universitas Andalas
90
Goodman (2009). Renal osteodystrophy. Dalam : Lerma EV, Berns JS, Nissenson
AR (eds). Current diagnosis & treatment : nephrology & hypertension.
United States : McGraw-Hill Companies.
Gomez AT, Kiber BA, Royston JP, Alfaadhel T, Soroka SD, Hemmelgarn BR
(2015). Comorbidity burden at dialysis initiation and mortality : A cohort
study. Canadian Journal of Kidney Health and Disease, 2 (34) : 1-9.
Grange S, Bertrand DM, Guerrot D, Eas F, Godin M (2010). Acute renal failure
and fanconi syndrome due to deferasirox. Nephrol Dial Transplant, 25 :
2376-2378.
Gunawan SG, Nafrialdi RS, Elysabeth (2009). Farmakologi dan terapi Edisi 5.
Jakarta : Balai Penerbit FKUI.
Guyton AC dan Hall JE (2007). Buku ajar fisiologi kedokteran edisi ke-11.
Jakarta: EGC.
Hahr AJ dan Molitch ME (2015). Management of diabetes mellitus in patients
with chronic kidney disease. Clinical Diabetes and Endocrinology, 1 (2) :
1-9.
Hassan Y, Ramahi RJ, Aziz NA, Ghazali R (2009). Drug use and dosing in
chronic kidney disease. Ann Acad Med Singapore, 38 (12) : 1095-1103.
Haze NK (2012). Chronic kidney disease pre-dialysis management : The action
plan. Medicine Update 2012, 22 : 618-624.
Hendromartono (2009). Nefropati diabetik. Dalam : Sudoyo AW, Setiyohadi B,
Alwi I, Simadibrata M, Setiati S (eds). Buku ajar ilmu penyakit dalam FK
UI jilid III. Edisi ke-5. Jakarta : Interna Publishing.
Humphreys BD, Soiffer RJ, Magee CC (2005). Renal failure associated with
cancer and its treatment : An update. J Am Soc Nephrol, 16 : 151-161.
IRR
(2012). 5th Report of Indonesia Renal Registry (IRR) 2012.
http://www.indonesianrenalregistry.org/data/INDONESIAN%20RENAL
%20REGISTRY%202012.pdf. Diunduh Oktober 2016.
Inrig JK (2010). Antihypertensive agents in hemodialysis patients : A current
perspective. Semin Dial, 23 (3) : 290-297.
Johnson CA (2010). 2010 Dialysis of drugs. United States : LLC Verona.
Kang HK dan Park Y (2015). Glycopeptide antibiotics : structure and mechanism
of action. Journal of bacteriology and virology, 45 (2) : 67-78.
Katzung BG, Masters SB, Trevor AJ (2012). Basic & clinical pharmacology 12th
edition. New York : Mc Graw Hill Companies.
Fakultas Kedokteran Universitas Andalas
91
KDIGO (2012a). KDIGO clinical practice guideline for the management of blood
pressure in chronic kidney disease. Kidney International Supplements, 2
(5) : 337-414.
KDIGO (2012b). KDIGO clinical practice guideline for anemia in chronic kidney
disease. Kidney International Supplements, 2(4) : 279-335.
KDIGO (2013a). KDIGO 2012 clinical practice guidelines for the evaluation and
management of chronic kidney disease. Kidney International Supplements,
3 (1): 1-150.
KDIGO (2013b). KDIGO clinical practice guideline for lipid management in
chronic kidney disease. Kidney International Supplements, 3 (3) : 259305.
Kelly J (2008). Micronutrient deficiency in chronic kidney disease. Nephrology
(Carlton), 13 (1) : 1-2.
Kemenkes RI (2014). Keputusan menteri kesehatan republik Indonesia nomor
159/menkes/SK/V/2014 tentang perubahan atas keputusan menteri
kesehatan nomor 328/menkes/SK/IX/2013 tentang formularium nasional.
Jakarta : Kementerian kesehatan RI.
Keparang J, Moeis ES, Rotty L (2013). Nilai trombosit pada pasien penyakit
ginjal kronik yang menjalani hemodialisis di unit hemodialisis
bagian/SMF ilmu penyakit dalam FK UNSRAT BLU RSUP Prof. Dr. R.
D. Kandou Manado. Fakultas Kedokteran. Skripsi. Universitas Sam
Ratulangi, Manado.
Kim AJ, Lim HJ, Ro H, Ko KP, Han SY, Chang JH, Lee HH et al. (2014). Lowdose aspirin for prevention of cardiovascular disease in patients with
chronic kidney disease. Plos One, 9 (8) : 1-9.
Koenig W (2012). Ramipril vs lisinopril in the treatment of mild to moderate
primary hypertension – A randomised double-blind multicentre trial.
http://springer.com/article/10.1007/BF03258424.html. Diakses Maret
2017.
Krol GD (2011). Chronic kidney disease staging and progression. Dalam : Yee J,
Krol GD (eds). Chronic kidney disease (CKD) Clinical practice
recommendations for primary care physicians and healthcare providers –
A collaborative approach 6th edition. United States : Henry Ford Health
System.
Kumar SV, Nagesh, dan Kumar GV (2013). A prospective study on prevalence,
dialysis and drug utilization of chronic renal failure patients. International
Journal of Pharmacology Research, 2 (2) : 42-52.
Langman CB dan Andia JBC, 2010. Calcium in chronic kidney disease : Myths
and realities. Clin J Am Soc Nephrol, 5 : S1-S2.
Fakultas Kedokteran Universitas Andalas
92
Lee JY, Kim HS, Park CS, Kim MC (2009). Erdosteine in renal ischemiareperfusion injury : an experimental study in pigs. J Vet Med Sci, 72 (1) :
127-130.
Lestariningsih (2012). Pelayanan hemodialisis dan perkembangan di Indonesia.
Dalam : Sja’bani M, Dharmeizar, Lestariningsih, Purwanto B (eds).
Naskah lengkap simposium nasional peningkatan pelayanan penyakit
ginjal kronik masa kini dan Indonesia Renal Registry Joglosemar 2012.
Yogyakarta : Pernefri Wilayah Yogyakarta.
Lin MY, Hwang SJ, Mau LW, Chen HC, Hwang SC, Wu LC et al. (2010). Impact
of late-Stage CKD and aging on medical utilization in the elderly
population : A closed-cohort study in Taiwan. Nephrol Dial Transplant, 25
: 3230-3235.
Liu KD dan Chertow GM (2010). Dialysis in the treatment of renal failure. Dalam
: Jameson JL, Loscalzo J (eds). Harrison’s nephrology and acid-base
disorders. United States : McGraw-Hill.
Liutic D, Perkovic D, Rumboldt Z, Bagatin J, Hozo I, Pivac N (2002).
Comparison of ondansetron with metoclopramide in the symptomatic
relief of uremia induced nausea and vomiting. Kidney Blood Press Res, 25
(1) : 61-64.
Macphee IA, Spreafico S, Bewick M, Davis C, Eastwood JB, Johnston A et al.
(2000). Pharmakokinetics of mycophenolate mofetil in patients with endstage renal failure. Kidney Int, Vol 57 (3) : 1164-1168.
Maerba M dan Ragnoli B (2008). Ambroxol in the 21st century : Pharmacological
and clinical update. Expert Opin Drug Metab Toxicol, 4 (8) : 1119-1129.
Maker GL, Siva B, Batty KT, Trengove RD, Ferrari P, Olynyk JK (2013).
Pharmacokinetics and safety of deferasirox in subjects with chronic kidney
disease undergoing heamodialysis. Nephrology (Carlton), 18 (3) : 188193.
Malliara M (2007). The management of hypertension in hemodialysis and CAPD
patients. Hippokratia, 11 (4) : 171-174.
Manley HJ, Drayer DK, Muther RS (2003). Medication-related problem type and
appearance rate in ambulatory hemodialysis patients. BMC Nephrology, 4
(10) : 1-7.
Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WK, Neufeld TK, et al.
(2004). Medication prescribing patterns in ambulatory haemodialysis
patients : Comparisons of USRDS to a large not-for-profit dialysis
provider. Nephrol Dial Transplant, 19 (7) : 1842-1848.
Fakultas Kedokteran Universitas Andalas
93
McQuillan R, Trpeski L, Fenton S, Lok CE (2012). Modifiable risk factors for
early mortality on hemodialysis. International Journal of Nephrology, 12 :
1-6.
Mimi N, Medregoniu D, Olteanu M, Golli A, Olteanu M, Macaseanu A, et al.
(2011). Tuberculosis and chronic renal failure : Therapy patterns. Current
Helath Sciences Journal, 37 (2) :106-108.
Mims (2016). Erdosteine. http://mims.com/indonesia/drug/info/erdosteine.html.
Diakses September 2016.
Monegat M, Sermet C, Perronnin M, Rococ E (2014). Polypharmacy : Definitons,
measurement and stakes involved review of the literature and
measurement tests. IRDES, 204 : 1-8.
NKF (2014). A clinical update on gout : optimizing care for patients with chronic
kidney disease. New York : National Kidney Foundation.
NKF K/DOQI (2002). K/DOQI clinical pracitice guidelines for chronic kidney
disease : evaluation, classification, and stratification. American Journal of
Kidney Disease, 39 (2) : S1-S266.
Panwar B, Johnson VA, Patel M, Balkovetz DF (2013). Risk of vancomysininduced nephrotoxicity in the population with chronic kidney disease. Am
J Med Sci, 345 (5) : 396-399.
Pardede DKB (2012). Gangguan gastrointestinal pada penyakit ginjal kronis.
CKD-195, 39 (7) : 501-507.
PDPI/Perhimpunan Dokter Paru Indonesia (2011). Pedoman diagnosis dan
penatalaksanaan tuberkulosis di Indonesia. Jakarta : Perhimpunan dokter
paru Indonesia.
Pernefri/Perhimpunan Nefrologi Indonesia (2011). Konsensus manajemen anemia
pada penyakit ginjal kronik. Jakarta : Pernefri.
Pham PCT, Toscano E, Pham PMT, Pham PAT, Pham SV, Pham PTT (2009).
Pain management in patients with chronic kidney disease. NDT Plus, 2 :
111-118.
Pramitasari RI (2011). Studi penggunaan obat pada pasien penyakit ginjal kronik
yang mengalami problem medis selama proses hemodialisis. Fakultas
Farmasi. Skripsi, Universitas Airlangga, Surabaya.
Price SA dan Wilson LM (2005). Patofisiologi, konsep klinis proses-proses
penyakit volume 2. Edisi ke-6. Jakarta : EGC.
Fakultas Kedokteran Universitas Andalas
94
Prodjosudjadi W (2006). Incidence, prevalence, treatment and cost of end-stage
renal disease in Indonesia. Ethnicity & Disease, 16 : 14-16.
Provenzano R (2009). Anemia & chronic kidney disease. Dalam : Lerma EV,
Berns JS, Nissenson AR (eds). Current diagnosis & treatment nephrology
& hypertension. United States : McGraw-Hill.
Pusparini (2000). Perubahan respons imun pada penderita gagal ginjal kronik
yang menjalani hemodialisis. J Kedokter Trisakti, 19 (3) : 115.
Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D et al. (2011). Folic
acid therapy and cardiovascular disease in ESRD or advanced chronic
kidney disease : A meta-analysis. Clin J Am Soc Nephrol, 6 (3) : 482-488.
Rahardjo P, Susalit E, Shuardjono (2009). Hemodialisis. Dalam : Sudoyo AW,
Setiyohadi B, Alwi I, Simadibrata M, Setiati S (eds). Buku ajar ilmu
penyakit dalam FK UI jilid II edisi ke-5. Jakarta : Interna Publishing.
Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV
(2012). Assesment of drug-drug interactions among renal failure patients
of nephrology ward in a South Indian tertiary care hospital. Indian J Pharm
Sci, 74 (1) : 63-68.
Rhambade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A (2012). A
survey on polypharmacy and use of inappropriate medications. Toxicol
Int, 19 (1) : 68-73.
Rifkin BS dan Perazella MA (2005). Analgesic therapy in patients with chronic
kidney disease : A case-based approach. Hospital Physician, 43 : 13-22.
Sachdeva M, Lahoti A, Mathew A (2015). Chronic kidney disease in cancer
patients. Dalam : Jhaveri, Kenar D, Salahudeen, Abdulla K (eds).
Onconephrology : cancer, chemotherapy and the kidney. New York :
Springer.
Schreiner O, Wandel E, Himmelsbach F, Galle PR, Marker E (2000). Reduced
Secretion of Proinflammatory Cytokines of Monosodium Urate CrystalStimulated Monocytes in Chronic Renal Failure: An Explanation for
Infrequent Gout Episodes in Chronic Renal Failure Patients. NDT, 15 :
644-649.
Seyffart G (2012). Drug dosage in renal insufficiency. Kidney International, 81 :
931-932.
Sherwood L (2001). Fisiologi manusia dari sel ke sistem edisi ke-2. Jakarta :
EGC.
Singapuri MS dan Lea JP (2010). Management of hypertension in the end-stage
renal disease patient. JCOM, 17 (2) : 87-95.
Fakultas Kedokteran Universitas Andalas
95
Smyth B, Jones C, Saunders J (2016). Prescribing for patients on dialysis.
Australian Prescriber, 39 (1) : 21-24.
Sousa AD (2008). Psychiatric issues in renal failure and dialysis. Indian Journal of
Nephrology, 18 (2) : 47-50.
Spiegel DM dan Moore R (2009). The patient receiving chronic renal replacement
with dialysis. Dalam : Schrier RW (ed). Manual of nephrology. Edisi ke-7.
Philadelphia : Lippincott Williams & Wilkins.
Steiber AL dan Kopple JD (2011). Vitamin status and needs for people with
stages 3-5 chronic kidney disease. Journal of Renal Nutrition, 21 (5) : 355368.
Stengel B (2010). Chronic kidney disease and cancer : A troubling connection.
Jnephrol, 23 (3) : 253-262.
Stringer JL (2006). Konsep dasar farmakologi : Panduan untuk mahasiswa.
Jakarta : Penerbit buku kedokteran EGC.
Sukandar E (2006). Nefrologi klinik edisi ketiga. Bandung : Pusat Informasi
Ilmiah Bagian Ilmu Penyakit Dalam FK UNPAD/RS Hasan Sadiki.
Suwitra K (2009). Penyakit ginjal kronik. Dalam : Sudoyo AW, Setiyohadi B,
Alwi I, Simadibrata M, Setiati S (eds). Buku ajar ilmu penyakit dalam FK
UI jilid II edisi ke-5. Jakarta : Interna Publishing.
Tamilselvan T, Veerapandiyan AK, Karthik N (2014). Study on drug utilization of
chronic renal failure patients in a tertiary care hospital. Int J Pharm Pharm
Sci, 6 (9) : 482-484.
Tan KS dan Johnson DW (2008). Managing the cardiovascular complications of
chronic kidney disease. Aust Prescr, 31 (6) : 154-158.
Tattersal J, Dekker F, Heimburger O, Jager KJ, Lameire N, Lindley E et al.
(2011). When to start dialysis : update guidance following publication of
the initiating dialysis early and late (IDEAL) study. Nephrol Dial
Transplant, 1 : 1-5.
USRDS (2014). The 2014 annual data report : chronic kidney disease in the
United States volume 1. http://www.usrds.org/2014/view/Default.aspx.
Diunduh Oktober 2015.
Utami SK (2011). Studi penggunaan obat pada pasien rawat jalan dengan penyakit
ginjal kronik yang menjalani hemodialisis. Fakultas Farmasi. Skripsi,
Universitas Airlangga, Surabaya.
Veehof LJG, Stewart RE, Ruskamp FMH, Jong BM (2000). The development of
polypharmacy : A longitudinal study. Family Practice, 17 (3) ; 261-267.
Fakultas Kedokteran Universitas Andalas
96
Vlassara H, Ferrucci L, Post J, Striker G (2009). Decline of renal function in
normal aging, role of oxidants / inflammation : When does it begin : Is it
inevitable, preventable, or treatable? Dalam : Miller M, Hare AM, Shim
RL (eds). Geriatric Nephrology Curriculum. Washington : American
Society of Nephrology.
Winalda GA (2016). Evaluasi ketepatan terapi obat pada pasien gagal ginjal di
instalasi rawat inap RS “X” tahun 2014. Fakultas Farmasi. Skripsi.
Universitas Muhammadiyah Surakarta, Surakarta.
Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC
(2009). Association of CKD and cancer risk in older people. J Am Soc
Nephrol, 20 : 1341-1350.
Woredekal Y (2009). Diabetic nephropathy. Dalam : Lerma EV, Berns JS,
Nissenson AR (eds). Current diagnosis & treatment : nephrology &
hypertension. United States : McGraw-Hill Companies.
Zadeh KK, Zadeh KK, dan Lee GH (2006). The fascinating but deceptrive feritrin
: to measure it or not to measure it in chronic kidney disease. Clin J Am
Soc Nephrol, 1 : S9-S18.
Zadeh KK dan Koople JD (2009). Chronic renal failure & the uremic syndrome :
Nutritional issue. Dalam : Lerma EV, Berns JS, Nissenson AR (eds).
Current diagnosis & treatment : nephrology & hypertension. United States
: McGraw-Hill Companies.
Zalunardo N dan Levin A (2009). Cardiovascular disease in chronic kidney
disease. Dalam : Lerma EV, Berns JS, Nissenson AR (eds). Current
diagnosis & treatment : nephrology & hypertension. United States :
McGraw-Hill Companies.
Fakultas Kedokteran Universitas Andalas
97